A carregar...
New Developments in the Treatment of X-Linked Hypophosphataemia: Implications for Clinical Management
X-linked hypophosphataemia (XLH) is due to mutations in phosphate-regulating gene with homologies to endopeptidases on the X chromosome (PHEX) and represents the most common heritable form of rickets. In this condition, the hormone fibroblast growth factor 23 (FGF23) is produced in excessive amounts...
Na minha lista:
| Publicado no: | Paediatr Drugs |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer International Publishing
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7083817/ https://ncbi.nlm.nih.gov/pubmed/31965544 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40272-020-00381-8 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|